tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

ONCY Stock Latest News

Advancing Pelareorep: Compelling Early Efficacy and High-Risk, High-Reward Valuation Support Buy Rating and $3 Target
RatingsAdvancing Pelareorep: Compelling Early Efficacy and High-Risk, High-Reward Valuation Support Buy Rating and $3 Target
12h ago
ONCY
Oncolytics Biotech Data Signal Registration Path for Pelareorep Combo in Third-Line Anal Cancer
PremiumCompany Announcements
Oncolytics Biotech Data Signal Registration Path for Pelareorep Combo in Third-Line Anal Cancer
1d ago
ONCY
Oncolytics announces updates data from GOBLET cohort 4
PremiumThe Fly
Oncolytics announces updates data from GOBLET cohort 4
2d ago
ONCY
Oncolytics Biotech Seeks Nevada Domestication to Align with U.S. Growth Strategy
PremiumCompany Announcements
Oncolytics Biotech Seeks Nevada Domestication to Align with U.S. Growth Strategy
5d ago
ONCY
Oncolytics outlines strategic rationale for proposal to change jurisdiction
PremiumThe Fly
Oncolytics outlines strategic rationale for proposal to change jurisdiction
5d ago
ONCY
Oncolytics Biotech Moves to Extend Pelareorep Patent Runway Beyond 2044
PremiumCompany AnnouncementsOncolytics Biotech Moves to Extend Pelareorep Patent Runway Beyond 2044
6d ago
ONCY
Oncolytics Biotech Adds Leading GI Oncologists to Advisory Board as It Prepares Pivotal Pelareorep Trials
Premium
Company Announcements
Oncolytics Biotech Adds Leading GI Oncologists to Advisory Board as It Prepares Pivotal Pelareorep Trials
7d ago
6K
ONCY
Promising Potential of Oncolytics Biotech’s Pelareorep in KRAS-Mutant MSS Colorectal Cancer Drives Buy Rating
Premium
Ratings
Promising Potential of Oncolytics Biotech’s Pelareorep in KRAS-Mutant MSS Colorectal Cancer Drives Buy Rating
28d ago
ONCY
Oncolytics Biotech Reports Promising Pelareorep Data in Colorectal Cancer
PremiumCompany Announcements
Oncolytics Biotech Reports Promising Pelareorep Data in Colorectal Cancer
29d ago
ONCY
Oncolytics reports clinical, translational findings from pelareorep development
PremiumThe Fly
Oncolytics reports clinical, translational findings from pelareorep development
29d ago
ONCY
Oncolytics Biotech Plans Jurisdiction Shift to Nevada
PremiumCompany Announcements
Oncolytics Biotech Plans Jurisdiction Shift to Nevada
1M ago
ONCY
Oncolytics management to meet virtually with Lake Street
PremiumThe Fly
Oncolytics management to meet virtually with Lake Street
1M ago
ONCY
Oncolytics Biotech Reports Q3 2025 Financial Results
PremiumCompany AnnouncementsOncolytics Biotech Reports Q3 2025 Financial Results
2M ago
ONCY
Oncolytics Biotech Reschedules Shareholder Meeting Amid SEC Delays
Premium
Company Announcements
Oncolytics Biotech Reschedules Shareholder Meeting Amid SEC Delays
2M ago
6K
ONCY
Positive Buy Rating for Oncolytics Biotech Following FDA Endorsement of Pelareorep Phase 3 Trial
Premium
Ratings
Positive Buy Rating for Oncolytics Biotech Following FDA Endorsement of Pelareorep Phase 3 Trial
2M ago
ONCY
Oncolytics Biotech Aligns with FDA for Pivotal Pancreatic Cancer Study
PremiumCompany Announcements
Oncolytics Biotech Aligns with FDA for Pivotal Pancreatic Cancer Study
2M ago
6K
ONCY
Oncolytics aligns with FDA on pelareorep study design
PremiumThe Fly
Oncolytics aligns with FDA on pelareorep study design
2M ago
ONCY
Oncolytics Biotech: Strategic Advancements and Promising Clinical Data Justify Buy Rating
PremiumRatings
Oncolytics Biotech: Strategic Advancements and Promising Clinical Data Justify Buy Rating
2M ago
ONCY
Oncolytics Biotech Forms Advisory Board to Advance Pelareorep in GI Cancers
PremiumCompany Announcements
Oncolytics Biotech Forms Advisory Board to Advance Pelareorep in GI Cancers
2M ago
ONCY
Oncolytics price target raised to $10 from $5 at H.C. Wainwright
PremiumThe FlyOncolytics price target raised to $10 from $5 at H.C. Wainwright
2M ago
ONCY
Oncolytics Biotech Reports Increased Q3 Loss Amid Rising Expenses
Premium
Company Announcements
Oncolytics Biotech Reports Increased Q3 Loss Amid Rising Expenses
2M ago
6K
ONCY
Is ONCY a Buy, Before Earnings?
Premium
Pre-Earnings
Is ONCY a Buy, Before Earnings?
2M ago
ONCY

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >